It’s part of a larger battle between Louisiana officials and big health care companies over prescription drug prices.

CVS Health Corporation is rated a Buy with a strong turnaround driving industry-leading results. Learn more about CVS stock ...

CVS Health’s stock rose more than 2% on Tuesday after the company boosted its revenue and profit guidance for the year and ...

The healthcare giant expects its turnaround efforts to pay off as it raised its full-year outlook and expects that momentum ...

A Florida judge on Monday declared a mistrial in a lawsuit that accused Walmart, CVS and Walgreens of flooding the state with ...

CVS Health Corp. raised its full-year profit forecast and said earnings would rise in 2026, a sign of hope as it navigates a ...

CVS Health expects 2026 profit to beat Wall Street estimates and this year's projected earnings, it said on Tuesday, ...

CVS is a strong buy now, with rising earnings, solid dividends, and steady growth prospects despite industry challenges. Read ...

Fintel reports that on December 12, 2025, Bernstein maintained coverage of CVS Health (NYSE:CVS) with a Market Perform ...

BATON ROUGE, La. (WAFB) - Louisiana has settled two federal lawsuits against CVS Health Corporation and its pharmacy benefit ...

CVS Health Stock Gains on Guidance Raise. How It Expects to Perform in 2025 and Beyond.